Skip to main content
. 2003 Sep;12(9):2057–2062. doi: 10.1110/ps.0302503

Table 1.

List of proteins and polypeptides a

No. Protein Reference PDB L ln(kf) CO, % Abs_CO
30 S6 Otzen and Oliveberg 1999 1RIS 101 (97) 5.9 18.9 18.4
31 His-containing phosphocarrier protein Van Nuland et al. 1998b 1POH 85 2.7 17.6 15.0
32 N-terminal domain from L9 Kuhlman et al. 1998 1DIV 56 6.1 12.7 7.1
33 Villin 14T Choe et al. 1998 2VIK 126 6.8 12.3 15.4
34 Apomyoglobinl Cavagnero et al. 1999 1A6N 151 1.1 8.4 12.7
35 Colicin E7 immunity protein Ferguson et al. 1999 1CEI 87 (85) 5.8 10.8 9.2
36 Cro protein Laurents et al. 2000 2CRO 71 (65) 3.7 11.2 7.3
37 P16 protein Tang et al. 1999 2A5E 156 3.5 5.3 8.3
38 Twitching Ig repeat 27 Fowler and Clarke 2001 1TIT 89 3.6 17.8 15.8
39 CD2, 1st domain Parker et al. 1997 1HNG 98 (95) 1.8 16.9 16.0
40 Fibronectin tenth FN3 module Cota and Clarke 2000 1FNF 94 5.5 16.5 15.5
41 IFABP from rat Burns et al. 1998 1IFC 131 3.4 13.5 17.7
42 ILBPm Dalessio and Ropson 2000 1EAL 127 1.3 12.3 ± 0.5 15.7 ± 0.6
43 CRBP II Burns et al. 1998 1OPA 133 1.4 14.0 18.7
44 CRABP I Burns et al. 1998 1CBI 136 −3.2 13.8 18.8
45 tryptophan synthase α-subunitn Ogasahara and Yutani 1994 1QOP 268 (267) −2.5 8.3 22.3
46 GroEL apical domain (191–345) Golbik et al. 1998 1AON 155 0.8 13.7 21.2
47 Barstaro Schreiber and Fersht 1993 1BRS 89 3.4 11.8 10.5
48 Che Y Munoz et al. 1994 3CHY 129 (128) 1 8.7 11.2
49 Ribonuclease HIp Parker and Marqusee 1999 2RN2 155 0.1 12.4 19.3
50 DHFR (dihydrofolate reductase)q Jennings et al. 1993 1RA9 159 4.6 14.0 22.3
51 tryptophan synthase β2-subunitn Goldberg et al. 1990 1QOP 396 (390) −6.9 8.3 32.5
52 N-terminal domain from PGK Parker et al. 1995 1PHP 175 2.3 11.5 20.2
53 C-terminal domain from PGKr Parker et al. 1996 1PHP 219 −3.5 8.0 17.4
54 Barnase Matouschek et al. 1990 1BNI 110 (108) 2.6 11.4 12.3
55 T4 lysozymes Parker and Marqusee 1999 2LZM 164 4.1 7.1 11.6
56 Ubiquitint Khorasanizadeh et al. 1996 1UBQ 76 5.9 15.1 11.5
57 Suc 1u Schymkowitz et al. 2000 1SCE 113 (101) 4.2 11.8 11.9

h The folding of mutant protein Y34W was studied experimentally; we used the available PDB structure of wild type in our calculation of CO.

i The folding of mutant protein Y47W was studied experimentally; we used the available PDB structure of this mutant in our calculation of CO.

j The folding of mutant protein F56W was studied experimentally; we used the available PDB structure of mutant Y31H/Q36R in our calculation of CO.

k The folding of mutant protein C21S was studied experimentally; we used the available PDB structure of wild type protein in our calculation of CO.

l We used the available PDB structure of a holoform of myoglobin (but without heme) in our calculation of CO.

m We used the available PDB structure of mutant protein T118S from pig in our calculation of CO instead of the wild type protein from rat

n The folding of protein from Escherichia coli was studied experimentally. We used the available PDB structure of the same protein from Salmonella typhimurium in our calculation of CO.

o The folding of mutant protein C40A/C82A was studied experimentally; we used the available PDB structure of this mutant in our calculation of CO.

p The folding of mutant protein C13A/C63A/C133A was studied experimentally; we used the available PDB structure of wild type protein in our calculation of CO.

q The folding of wild type protein was studied. We used the available PDB structure of mutant protein N37D in our calculation of CO. ln(kf) value refers to the summary rate of two parallel pathways of refolding of DHFR.

r The folding of mutant protein W290Y was studied experimentally. We used the available PDB structure of wild type in our calculation of CO.

s The folding of Cys-free mutant was studied experimentally. We used the available PDB structure of wild-type protein in our calculation of CO.

t The folding of bovine protein F45W mutant was studied experimentally. We used the available PDB structure of WT human protein in our calculation of CO.

u There is only a strand-exchanged form of suc1 dimer in PDB. We used a concatenation of fragment 2–88 of chain C and fragment 89–102 of chain A as a tentative structure of monomeric protein in our calculation of CO.